Cardiac Biomarkers Testing Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
Cardiac Biomarkers Testing Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
— The Business research company
LONDON, GREATER LONDON, UNITED KINGDOM, September 30, 2024 /EINPresswire.com/ — The cardiac biomarkers testing market has experienced robust growth in recent years, expanding from $12.15 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, aging population, awareness and education initiatives, government initiatives and healthcare policies, increasing healthcare expenditure.
What Is The Estimated Market Size Of The Global Cardiac Biomarkers Testing Market And Its Annual Growth Rate?
The cardiac biomarkers testing market is projected to continue its strong growth, reaching $21.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to personalized medicine, rising global burden of cardiovascular diseases, integration of artificial intelligence (ai) in diagnostics, expansion of point-of-care testing, increasing emphasis on early disease detection.
Explore Comprehensive Insights Into The Global Cardiac Biomarkers Testing Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=9436&type=smp
Growth Driver Of The Cardiac Biomarkers Testing Market
The increasing prevalence of cardiovascular diseases is expected to boost the growth of the cardiac biomarkers testing market going forward. Cardiovascular disease refers to a type of condition that affects the heart or blood vessels. Cardiac biomarker tests assist in determining the levels of biomarkers to immediately determine the severity of a heart attack and its magnitude. Hence, an increase in the prevalence of cardiovascular diseases will lead to an increase in the demand for cardiac biomarker testing solutions.
Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Which Market Players Are Driving the Cardiac Biomarkers Testing Market Growth?
Key players in the market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech PLC, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam PLC, Bio-Techne Corporation.
What Are the Emerging Trends Shaping the Cardiac Biomarkers Testing Market Overview?
Major companies operating in the cardiac biomarker testing market are focusing on innovative products such as cardiac biomarkers to drive revenues in their market. Cardiac biomarkers, also known as cardiac enzymes, are substances that are released into the bloodstream when the heart muscle is damaged.
How Is The Global Cardiac Biomarkers Testing Market Segmented?
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Geographical Insights: North America Leading The Cardiac Biomarkers Testing Market
North America was the largest region in the market in 2023. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Cardiac Biomarkers Testing Market Definition
Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS).
Cardiac Biomarkers Testing Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Macroeconomic factors affecting the market in the short and long run
• Analysis of the macro and micro economic factors that have affected the market in the past five years
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
An overview of the global cardiac biomarkers testing market report covering trends, opportunities, strategies, and more
The Cardiac Biomarkers Testing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on cardiac biomarkers testing market size, cardiac biomarkers testing market drivers and trends and cardiac biomarkers testing market growth across geographies. This market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Cardiovascular Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Cardiac Assist Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report
Cardiac Pacemakers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
What Does The Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
